Neumora Therapeutics, Inc. (NMRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:38AM EDT. Market open.
| Previous close | 9.63 |
| Open | 9.65 |
| Bid | 9.41 x 100 |
| Ask | 9.50 x 100 |
| Day's range | 9.41 - 9.70 |
| 52-week range | 8.82 - 21.00 |
| Volume | |
| Avg. volume | 628,998 |
| Market cap | 1.501B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
- Zacks
Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
The FDA places a clinical hold on Neumora's (NMRA) phase I study evaluating NMRA-266 for some types of neuropsychiatric disorders. Shares of the company fall on the news.
© 2024 Yahoo. All rights reserved.